We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Incretin-based Therapy in Late Preclinical Type 1 Diabetes

This study is enrolling participants by invitation only.
Sponsor:
ClinicalTrials.gov Identifier:
NCT02898506
First Posted: September 13, 2016
Last Update Posted: October 26, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Oulu University Hospital
Tampere University Hospital
Turku University Hospital
Skane University Hospital
Information provided by (Responsible Party):
Riitta Veijola, University of Oulu
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is enrolling participants by invitation only.
  Estimated Study Completion Date: July 2019
  Estimated Primary Completion Date: July 2019 (Final data collection date for primary outcome measure)